
Predictive Oncology POAI
Annual report 2025
added 03-31-2026
Predictive Oncology DPO Ratio 2011-2026 | POAI
Annual DPO Ratio Predictive Oncology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.25 K | 5.54 K | 682 | 710 | 897 | 1.12 K | 2.17 K | 391 | 346 | 442 | 781 | 2.08 K | 2.04 K | 2.05 K | 4.44 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.25 K | 346 | 2.06 K |
Quarterly DPO Ratio Predictive Oncology
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22.2 K | 6.41 K | 2.28 K | - | 11 K | 10.8 K | 6.23 K | - | 1.02 K | 696 | 899 | - | 802 | 711 | 887 | - | 816 | 629 | 1.12 K | - | 715 | 1.47 K | 2.23 K | - | 1.38 K | 2.43 K | 2.23 K | - | 490 | 373 | 228 | - | 446 | 582 | 445 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.2 K | 228 | 2.95 K |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
63.6 | $ 76.58 | 1.05 % | $ 40.4 B | ||
|
Ekso Bionics Holdings
EKSO
|
91.4 | $ 11.19 | 1.85 % | $ 27.1 M | ||
|
The Cooper Companies
COO
|
72.6 | $ 64.76 | 0.52 % | $ 12.9 B | ||
|
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | ||
|
iRhythm Technologies
IRTC
|
7.87 | $ 125.16 | 2.3 % | $ 4.01 B | ||
|
Repro Med Systems
KRMD
|
46.1 | $ 3.94 | -0.51 % | $ 182 M | ||
|
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | ||
|
Milestone Scientific
MLSS
|
36.5 | $ 0.31 | -2.41 % | $ 25.4 M | ||
|
Haemonetics Corporation
HAE
|
41.9 | $ 59.95 | -0.05 % | $ 3.02 B | ||
|
electroCore
ECOR
|
195 | $ 6.1 | -1.21 % | $ 51.7 K | ||
|
ICU Medical
ICUI
|
39.2 | $ 121.97 | -2.29 % | $ 3.01 B | ||
|
Microbot Medical
MBOT
|
52.9 | $ 2.21 | 0.45 % | $ 101 M | ||
|
Envista Holdings Corporation
NVST
|
54.2 | $ 27.04 | 0.93 % | $ 4.54 B | ||
|
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
23.9 | $ 482.7 | 0.1 % | $ 172 B | ||
|
Glaukos Corporation
GKOS
|
67.2 | $ 123.75 | 1.72 % | $ 5.99 B | ||
|
STERIS plc
STE
|
31.8 | $ 221.43 | -0.17 % | $ 21.8 B | ||
|
Masimo Corporation
MASI
|
84.4 | $ 178.55 | -0.04 % | $ 9.52 B | ||
|
InfuSystem Holdings
INFU
|
62.5 | $ 10.83 | 4.94 % | $ 224 M | ||
|
Teleflex Incorporated
TFX
|
47.7 | $ 137.51 | 0.7 % | $ 6.14 B | ||
|
Merit Medical Systems
MMSI
|
30.3 | $ 68.43 | -0.22 % | $ 4.05 B | ||
|
Utah Medical Products
UTMD
|
17.8 | $ 68.25 | 1.61 % | $ 221 M | ||
|
Pulse Biosciences
PLSE
|
1.51 K | $ 23.51 | 2.11 % | $ 1.58 B | ||
|
West Pharmaceutical Services
WST
|
45.7 | $ 308.57 | 0.88 % | $ 22.3 B | ||
|
DENTSPLY SIRONA
XRAY
|
53.7 | $ 11.98 | 0.67 % | $ 2.39 B | ||
|
Retractable Technologies
RVP
|
46 | $ 0.65 | 1.41 % | $ 19.5 M | ||
|
Pro-Dex
PDEX
|
35.4 | $ 52.07 | -0.06 % | $ 171 M | ||
|
LeMaitre Vascular
LMAT
|
13.9 | $ 114.44 | 0.87 % | $ 2.59 B | ||
|
STAAR Surgical Company
STAA
|
74.3 | $ 26.27 | 2.34 % | $ 1.3 B | ||
|
BioLife Solutions
BLFS
|
130 | $ 21.82 | 2.06 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
124 | $ 1.92 | -0.78 % | $ 175 M | ||
|
Baxter International
BAX
|
45.6 | $ 18.38 | 1.24 % | $ 9.43 B | ||
|
ResMed
RMD
|
34.9 | $ 221.41 | 0.77 % | $ 32.3 B | ||
|
AtriCure
ATRC
|
68.7 | $ 28.94 | -1.16 % | $ 1.38 B | ||
|
Harvard Bioscience
HBIO
|
42 | $ 6.88 | 0.29 % | $ 305 M | ||
|
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
96.2 | $ 11.26 | 1.4 % | $ 460 M | ||
|
Becton, Dickinson and Company
BDX
|
59.3 | $ 153.02 | 0.59 % | $ 44 B | ||
|
Nephros
NEPH
|
50.5 | $ 2.89 | 0.7 % | $ 30 M | ||
|
OraSure Technologies
OSUR
|
40.1 | $ 3.01 | 0.33 % | $ 221 M | ||
|
Repligen Corporation
RGEN
|
24.3 | $ 118.66 | 0.9 % | $ 6.61 M |